Roche will pay $4.8 billion to acquire gene-therapy pioneer Spark Therapeutics
Tuesday, May 28, 2019 - 21:11
in Mathematics & Economics
The premium price indicates drug companies' growing interest in joining the gene-therapy field
Updated by artificial intelligence Tue, 13 Jun 2023, 2:53:47 UTC Learn more
- Tell your friends
- Get science news via